Antibody 15A9, raised with 5-phosphopyridoxyl (PPL)-N⑀ -acetyl-L-lysine as hapten, catalyzes the reversible transamination of hydrophobic D-amino acids with pyridoxal 5-phosphate (PLP). The crystal structures of the complexes of Fab 15A9 with PPL-L-alanine, PPL-D-alanine, and the hapten were determined at 2.3, 2.3, and 2.5 Å resolution, respectively, and served for modeling the complexes with the corresponding planar imine adducts. The conformation of the PLP-amino acid adduct and its interactions with 15A9 are similar to those occurring in PLPdependent enzymes, except that the amino acid substrate is only weakly bound, and, due to the immunization and selection strategy, the lysine residue that covalently binds PLP in these enzymes is missing. However, the N-acetyl-L-lysine moiety of the hapten appears to have selected for aromatic residues in hypervariable loop H3 (Trp-H100e and Tyr-H100b), which, together with Lys-H96, create an anion-binding environment in the active site. The structural situation and mutagenesis experiments indicate that two catalytic residues facilitate the transamination reaction of the PLP-D-alanine aldimine. The space vacated by the absent L-lysine side chain of the hapten can be filled, in both PLP-alanine aldimine complexes, by mobile Tyr-H100b. This group can stabilize a hydroxide ion, which, however, abstracts the C␣ proton only from D-alanine. Together with the absence of any residue capable of deprotonating C␣ of L-alanine, Tyr-H100b thus underlies the enantiomeric selectivity of 15A9. The reprotonation of C4 of PLP, the rate-limiting step of 15A9-catalyzed transamination, is most likely performed by a water molecule that, assisted by Lys-H96, produces a hydroxide ion stabilized by the anion-binding environment.The most often used approach for generating catalytic antibodies is to elicit antibodies against a haptenic group that mimics the transition state of the target reaction (1). The crystal structures of several antibodies obtained in this way validate this procedure and show the catalytic antibodies to bind and stabilize the transition state through van der Waals, hydrogen bonding, and electrostatic interactions (2, 3). Only by chance, these antibodies possess residues at the combining site that directly participate in the covalence changes of the reaction. The lack of catalytic residues is one of the reasons why the rate enhancement brought about by catalytic antibodies only occasionally approaches that of enzymes. The "bait and switch" strategy, which uses a charged hapten to elicit a programmed chemically reactive charged residue (4, 5), and the related procedure of "reactive immunization" (6) have been developed for obtaining catalytic antibodies endowed with reactive residues. Another possibility is to expand the catalytic scope of antibodies by incorporating a nonproteinaceous cofactor (7) that contributes to the catalytic efficacy while the antibody ensures substrate specificity and possibly reaction specificity. As yet, the structure of only one catalytic antibody tha...